tris syrup codeine​

Tris Syrup Codeine is a prescription cough medication commonly referring to a promethazine hydrochloride and codeine phosphate oral solution manufactured by Tris Pharma. Tris Syrup Codeine is formulated to suppress persistent cough and relieve associated upper respiratory symptoms such as runny nose, throat irritation, and sneezing. Because Tris Syrup Codeine contains codeine, an opioid antitussive, it is regulated as a controlled substance in many regions and must be dispensed under medical supervision.

codeine cough syrup tris

​The therapeutic action of codeine cough syrup tris depends on the pharmacodynamics of its components. Codeine suppresses the cough reflex by binding to opioid receptors in the central nervous system. By elevating the cough threshold, Tris Syrup Codeine reduces disruptive coughing episodes, particularly those that interfere with rest or recovery. Promethazine in codeine cough syrup tris works by inhibiting histamine activity in peripheral tissues and the central nervous system. This reduces symptoms such as runny nose, watery eyes, and throat irritation. Because promethazine crosses the blood–brain barrier, Tris Syrup Codeine often produces sedation, which may contribute to improved nighttime symptom control.

tris codeine syrup

Because tris codeine syrup suppresses the cough reflex, it is not appropriate for productive coughs where mucus clearance is necessary. Clinical evaluation ensures that tris codeine syrup is used in appropriate therapeutic scenarios.